Close Menu

NEW YORK (GenomeWeb) – MDxHealth has exclusively licensed Ghent University's proprietary molecular diagnostic visualization technology to enable the detection of cancer associated epigenetic changes in both tissue and liquid samples, the company said today.

Separately, the two parties forged a research and development agreement to develop in vitro diagnostic kits and laboratory-developed tests based on the technology.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.